In vitro diagnostics are tests that diagnose and
prevent diseases, conditions or infections. IVD tests are performed outside
body in an artificial environment on samples such as blood, urine, tissue
isolated from human body. IVD is classified into 3 types namely: clinical
laboratory testing, near-patient testing, self-testing. IVD market is segmented
by-techniques (including immunoassays, point of care, molecular diagnostics,
hematology, coagulation, microbiology, clinical techniques, microbiology),
product-type (including instruments, reagents, services, data management
systems), usability (including disposable, reusable), applications (including
diabetes, oncology, cardiology, HIV/AIDS, autoimmune disease, nephrology, drug
testing), -end-user (including hospitals, laboratories, academics) and
geography (globally).
The global IVD market was reported with high revenue
in previous years and hence expected to grow at a high CAGR by 2019. The
Asia-Pacific and RoW regions are expected to register a significant growth rate
for the IVD market. North America commands the largest share while Asia Pacific
is the fastest revenue growing region.
IVD market growth is driven by factors such as
increase in incidences of chronic and infectious diseases across all age cohorts,
genetic diseases, aging population, rising acceptance of personalized medicine,
rise in healthcare awareness in patients and high unmet medical needs in
diagnosing diseases. Screening initiatives and high investment in healthcare
infrastructures mainly contributes to market growth. Whereas, difficulty in
rendering rapid diagnostic results, stringent regulatory policies,
reimbursement issues and economic crisis are the major growth restraints.
Different geographies is an opportunistic factor which improved IVD market
growth.
Roche diagnostics (Basel, Switzerland) is expected to
be the largest player in the IVD market, followed by Siemens and Abbott. The
IVD market is highly consolidated, with the major players holding close to 80%
market share. Top ten major players are Roche Diagnostics, Siemens
Healthcare(Erlangen, Germany), Abbott(Abbott Park, Illinois), Johnson and
Johnson(New Jersey), Beckman Coulter(Massachusetts), Becton Dickinson(U.S.),
bioMerieux (France), Bayer Diabetes(Germany), Sysmex (U.S.) and
Bio-Rad(California). Key players such as Thermo Fisher Scientific, Inc., QIAGEN
N.V., and ARKRAY, Inc. have established new manufacturing facilities and
R&D units in China to grow IVD market.
The focus of this research report description was on
various levels of analysis, industry, market shares, value chain, PESTEL
analysis and company profiles which together comprise and augment about
competitive landscape, emerging and high growth segments of in vitro diagnostic
(molecular diagnostics & point of care testing), emerging technologies.
The report provides an in depth market analysis of
the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Spanning over 239 pages “In Vitro Diagnostics (POC/Rapid diagnostics) Global
market - Forecast to 2020” report covers the Executive
Summary, Introduction, Market Analysis, Global Ivd Market, By Technique, Global
Ivd Market, By Products, Global Ivd Market, By Application, Global Ivd Market,
By End-Users, Regional Market Analysis, Company Developments, Major Player
Profiles. The report covered companies are - Abbott Laboratories, Inc., Becton,
Dickinson and company, Biomerieux, Bio-Rad Laboratories, Inc., Danaher
Corporation, Johnson and Johnson, Roche Diagnostics, Siemens Healthcare, Sysmex
Corporation, Thermo Fischer Scientific, Inc.
For further information on this report, please visit- http://mrr.cm/4fT
Find all Pharma and
Healthcare Technology Reports at:
No comments:
Post a Comment
Note: only a member of this blog may post a comment.